Skip to main content
. 2020 Mar 4;9(3):689. doi: 10.3390/jcm9030689

Figure 2.

Figure 2

Long-term oncologic outcomes of resected pancreatic cancer according to IOT (a) represents the comparison of disease-specific survival rates between the patients who received IOT and those who did not. (b) represents the comparison of recurrence rates between the patients who received IOT and those who did not.